REMS assessments found no cases of Torsades de pointes or unexplained sudden deaths among patients taking vandetanib during ...

The UK’s Debt Management Office (DMO) only managed to sell £4.75 billion in five-year government debt on Wednesday, but the ...

However, the FDA said that after over more than a decade of oversight, REMS assessments reported no cases of torsades de ...

Bullish Case: A cautious BoE, pausing rate cuts but slowing QT sales, would reassure bond investors and stabilize yields. A less aggressive stance could also support equities, especially ...

QT Medical Inc, today announced it has been named a finalist for the Best Innovation in Medical Technology – Device category at Octane's 2025 High Tech Awards. The winners will be announced at a gala ...

FDA lifts REMS program for vandetanib, affirming safety in thyroid cancer treatment as healthcare providers ensure effective ...

Earlier, the Bank of England maintained the Bank Rate at 4% as expected, on a 7-2 vote split, and reduced the Quantitative Tightening (QT) from £100 billion to £70 billion. Worth noting, in the ...

Yields on 30-year US bonds have fallen around 25 basis points since early September, while those on UK gilts have dropped 20 basis points and their Japanese counterparts have fallen nearly 15 basis ...

Hidden cardiac conditions can exist silently - sometimes showing up only during intense physical activity. Even those who ...

Since its approval, there have been no cases of torsades de pointes or unexplained sudden death among US patients treated with Caprelsa.